drugset / Trial / NCT00583700

Trental & Vitamin E for Radiation-Induced Fibrosis

NCT00583700

Phase 2 Completed 54 enrolled University of Iowa
RandomizedParallel-groupOpen-labelPrevention

Summary

This study seeks to determine if a combination of Trental and Vitamin E prevents the development of radiation fibrosis in women treated with radiation for the definitive management of their breast cancer.

Timeline

Start
2003-02
Primary completion
2010-05
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Pentoxifylline Small molecule 400 mg
Subject Vitamin E Other / unclassified 400 iu

Indications